Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Centrum zdravi Dolni Brezany a.s.

Czechia Delnicka 120, 252 41 Dolni Brezany, Czechia

  • Type 2 diabetes mellitus · Obesity
  • Adult patients

About Specializations

Centrum zdravi Dolni Brezany a.s. in Dolni Brezany, Czechia specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

Research at Centrum zdravi Dolni Brezany a.s. targets cardiovascular diseases among individuals with type 2 diabetes who have heightened heart risk.

  • Evaluation of novel diabetes medicines for heart safety
  • Comparison of insulin alternatives for glycemic control
  • Long‑term outcomes of combined metabolic and cardiovascular therapies

The site’s work aims to improve treatment effectiveness and reduce cardiovascular events in high‑risk populations.

Nutritional and Metabolic Diseases

The department investigates nutritional and metabolic diseases, emphasizing obesity and weight management in patients with or without type 2 diabetes.

  • Testing combined semaglutide and cagrilintide for weight reduction
  • Assessing lifestyle‑enhanced pharmacotherapy for obesity
  • Measuring impact of new agents on body mass and metabolic markers

By integrating diet, activity, and medication, the center seeks to advance effective obesity treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Delnicka 120252 41 Dolni BrezanyCzechia
Open in maps ↗
Recruiting now
no trials
Conditions studied
2

More sites in Dolni BrezanyCzechia

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Type 2 diabetes mellitus

Not yet recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Obesity

Not recruiting
InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.